About Geoffrey Marshall
Form D filings for Sus Clinicals in 2024 list Geoffrey Marshall as executive officer and director.
Geoffrey Marshall first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Geoffrey Marshall in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Geoffrey Marshall works with at each company, as listed on that company's latest Form D.
Sus Clinicals, Inc. · Form D, Jan 10, 2024
SB
Stephen Baggott
Executive officer and director
JW
Jeffrey Weedman
Executive officer and director